Scientific name/commonly used name
Scientific names: 1. Panax ginseng C.A. Meyer and 2. Panax quinquefolius L.
Common names: 1. Asian ginseng and 2. American ginseng
The genus Panax
The genus Panax (C. Linnaeus) belongs to the family Araliaceae or ivy plants. From a medical point of view the most important species are Panax ginseng C.A. Meyer and P. quinquefolius L. Additionally, numerous other Panax species exist. In colloquial terms plants of other genera such as, for instance, Eleutherococcus senticosus and Pfaffia paniculata are labelled as “Siberian ginseng” and “Brazilian ginseng” respectively. As a result of a farm bill passed by the US Congress, the FDA ruled that the term "ginseng" could only be associated with the genus Panax - with an appendage instigated by the American Ginseng Growers Association, directed mainly against marketing of so-called "Siberian ginseng".1 P. ginseng and P. quinquefolius are practically the only cultivated species. Especially crème-colored roots are being used for medical purposes. Ginseng roots consist of the primary root, lateral roots and rootlets (hair roots) usually harvested at 4-7 years old.1 In countries such as Canada and South Korea ginseng is sometimes harvested earlier to obviate extensive fungal deterioration.
Main substances
Ginseng roots contain a complex multi-component mixture. The putative main active compounds are ginsenosides, triterpene glycosides, which are saponins, a class of secondary metabolites prevalently found in the plant kingdom.2 Ginsenosides are bitter-tasting, surface active, glycosidic compounds. Through sour or enzymatic hydrolysis they are converted to a triterpene part, the so-called aglycone, and a sugar part. The sugar proportion consists of chains of multiple monosaccharides variously linked to the aglycone.3,4 In chromatography, ginsenosides are labeled with letters and index numbers according to their rate of elution (e.g. Ra1, Rb1, Rg1). So far 38 different types of ginsenosides have been described from P. ginseng and 19 from P. quinquefolius.3 Quantitatively, Rg1 and Rb1 have the greatest significance and are thus labeled as the main ginsenosides. P. ginseng contains more Rg1 than does P. quinquefolius.3,5 Depending on the section of the root, the age of the plant and the manufacturing process (e.g. red or white ginseng), the content and composition of the ginsenosides can vary considerably.4,6,7 The content of ginsenosides is considered to be the quality measurement of a ginseng root: the more variability in content of various types of ginsenosides and the larger quantities of the individual ginsenosides there are, the higher the quality (and the cost) of the root.8 Apart from the ginsenosides, the ginseng root also contains a number of additional substances, including polysaccharides, fatty acids, vitamins, essential oils, trace elements, amino acids.4,8 Ginsan, which is a polysaccharide, has shown to have immunomodulatory effects.9
History / providers
For thousands of years P. ginseng has been regarded in Asia as a panacea, promoting health and longevity.1 At the beginning of the 18th century the Jesuit father Lafitau discovered P. quinquefolius just outside present day Montreal. The plant has been used for hundreds of years by native Americans as a medicinal plant.10 Both ginseng species are still quite extensively used.
Nowadays P. quinquefolius is mainly cultivated in some parts of Canada, in a number of states in the U.S., predominantly Wisconsin and New York, and now also in China. P. ginseng is mainly produced in South Korea, with an annual production of more than 11 thousand tons.8 Apart from being cultivated in their countries of origin, P. ginseng and P. quinquefolius are also grown in many other countries (notably Australia and Germany) and are currently some of the most popular herbal products. Ginseng products which are advertised for healing purposes can be purchased almost anywhere, for instance, at chemists’, in health food stores, drug stores and over the Internet. Ginseng preparations differ in their composition, preservative agents and binding agents.8 This makes it particularly difficult to compare products with one another. Additionally, ginseng can also be found in other products, such as cosmetics, food supplements, teas and soft drinks.
Claims of efficacy / mechanisms of action / claimed indications
Ginseng is used as a tonic for strengthening and invigoration in cases of fatigue and weakness as well as in reduced performance and concentration,11 which also is in accordance with its traditional use in Asian medicine.12,13 From a phytopharmacological point of view, the ginsenosides, particularly Rg1 and Rb1, as well as their metabolites which are produced in the gastrointestinal tract, are thought to be the active agents.3,13,14 Some of the effects possibly result from a modulation of the hypothalamus-pituitary axis or of the central monoamine neurotransmitter system.15 However, ginsenosides have also shown differential effects: Rg1 might work as a stimulant, whereas Rb1 might have more inhibitory effects on functions of the central nervous system.4,16,17 It is, as for other multicomponent herbal extracts, unclear as to what extent the different ginsenosides play a part in ginseng’s overall mechanism of action.8 In Traditional Chinese Medicine, ginseng has been used for thousands of years for balancing what is referred to as the so-called yin-yang equilibrium. P. ginseng is supposed to act as a “warming” substance and thereby strengthen what in Chinese Medicine is called “Yang”; whereas P. quinquefolius is claimed to have a “cooling” effect and strengthens “Yin”.12,18 This could possibly be explained by P. quinquefolius having higher concentrations of ginsenosides. P. ginseng however, possesses a greater variety of ginsenosides.10
Pharmacological aspects
Ginsenosides are deglycosylated in stages in the digestive tract and their metabolites seem to be more active than the ginsonosides themselves.19 Depending on the individual intestinal flora this biotransformation process takes its course to varying degrees.20 Generally, fractions of ginsenosides, which are partly still glycosylated, are resorbed and are bound to serum albumin in the blood.6,7 As a whole, resorption and bioavailability of the ginsenosides after oral consumption are low.10,19 For instance, the latter amounts to 0.1-4% for Rb1 and 2-18% for Rg.19 The elimination of the ginsenosides occurs after attachment to glucuron acid via urine and stool.
Application
Ginseng is one of the most consumed plant products worldwide.8 For healing purposes, the roots are primarily used (primary root, lateral roots and rootlets hair roots) – and mostly as dried powders or extracts. Recommendations for dosage vary from country to country, also within Europe. In Germany a daily dosage of 1-2 g of dried root with a minimum content of 1.5% ginsenosides is recommended (= 1.5g per 100g dried root, calculated for ginsenoside Rg1), which equals 15–30 mg ginsenosides per day.7 In Asian countries, dosage recommendations are much higher than in Europe, the Chinese pharmacopeia for instance recommends 3-9 g root and thus a daily dosage of 45-136 mg ginsenosides. Ginseng is supposed to be consumed 1-2 times daily with plenty of liquid. It is recommended that its application is interrupted after 3 months for a certain period of time.
For therapeutic use of P. quinquefolius for cancer-related fatigue, dosage recommendations are available from clinical studies. These range from 750 mg to 2.000 mg per day.21,22
Shelf life / storage
Ginseng root needs to be kept away from light and humidity and must be stored in air-tight containers. Its shelf life is at least one year. For ginseng products such as capsules and tablets, specified expiry dates apply.
Aspects of pharmaceutical drug and law regulations
The content of ginsenosides according to the European Pharmacopoeia has to be 6.0–12.0% of the sum of ginsenosides (Rb1, Rb2, Rc, Rd, Re Rf, Rg1 and Rg2) expressed as ginsenosides Rb1 (dried extract).23 In Germany for instance, P. ginseng has been licensed as an over-the-counter (OTC) drug by the Federal Institute for Pharmaceuticals (Bundesinstitut für Arzneimittel, BfArm). For those OTC drugs licensed in Germany a minimum content of 1.5% ginsenosides is required.
Costs and expenditures
Costs vary depending on the quality of the ginseng. Daily costs for drugs licensed in Germany amount to approximately 1-3 Euros.
